77 research outputs found
N-acetyl-cysteinylated streptophenazines from Streptomyces
Here, we describe two N-acetyl-cysteinylated streptophenazines (1 and 2) produced by the soil-derived Streptomyces sp. ID63040 and identified through a metabolomic approach. These metabolites attracted our interest due to their low occurrence frequency in a large library of fermentation broth extracts and their consistent presence in biological replicates of the producer strain. The compounds were found to possess broad-spectrum antibacterial activity while exhibiting low cytotoxicity. The biosynthetic gene cluster from Streptomyces sp. ID63040 was found to be highly similar to the streptophenazine reference cluster in the MIBiG database, which originates from the marine Streptomyces sp. CNB-091. Compounds 1 and 2 were the main streptophenazine products from Streptomyces sp. ID63040 at all cultivation times but were not detected in Streptomyces sp. CNB-091. The lack of obvious candidates for cysteinylation in the Streptomyces sp. ID63040 biosynthetic gene cluster suggests that the N-acetyl-cysteine moiety derives from cellular functions, most likely from mycothiol. Overall, our data represent an interesting example of how to leverage metabolomics for the discovery of new natural products and point out the often-neglected contribution of house-keeping cellular functions to natural product diversification
Recommended from our members
Minimum Information about a Biosynthetic Gene cluster
A wide variety of enzymatic pathways that produce specialized metabolites in bacteria, fungi and plants are known to be encoded in biosynthetic gene clusters. Information about these clusters, pathways and metabolites is currently dispersed throughout the literature, making it difficult to exploit. To facilitate consistent and systematic deposition and retrieval of data on biosynthetic gene clusters, we propose the Minimum Information about a Biosynthetic Gene cluster (MIBiG) data standard.Chemistry and Chemical Biolog
Megalochelin, a Tridecapeptide Siderophore from a Talented Streptomycete
Streptomycetes are bacteria known for their extraordinary biosynthetic capabilities. Herein, we describe the genome and metabolome of a particularly talented strain, Streptomyces ID71268. Its 8.4-Mbp genome harbors 32 bioinformatically predicted biosynthetic gene clusters (BGCs), out of which 10 are expressed under a single experimental condition. In addition to five families of known metabolites with previously assigned BGCs (nigericin, azalomycin F, ectoine, SF2766, and piericidin), we were able to predict BGCs for three additional metabolites: streptochlorin, serpetene, and marinomycin. The strain also produced two families of presumably novel metabolites, one of which was associated with growth inhibitory activity against the human opportunistic pathogen Acinetobacter baumannii in an iron-dependent manner. Bioassay-guided fractionation, followed by extensive liquid chromatography-mass spectrometry (LC-MS) and NMR analyses, established that the molecule responsible for the observed antibacterial activity is an unusual tridecapeptide siderophore with a ring-and-tail structure: the heptapeptide ring is formed through a C-C bond between a 2,3-dihydroxybenzoate (DHB) cap on Gly1 and the imidazole moiety of His7, while the hexapeptide tail is sufficient for binding iron. This molecule, named megalochelin, is the largest known siderophore. The megalochelin BGC encodes a 13-module nonribosomal peptide synthetase for the synthesis of the tridecapeptide, and a copper-dependent oxidase, likely responsible for the DHB-imidazole cross-link, whereas the genes for synthesis of the DHB starter unit are apparently specified in trans by a different BGC. Our results suggest that prolific producers of specialized metabolites may conceal hidden treasures within a background of known compounds
A Calibration Technique for the Estimation of Lung Volumes in Nonintubated Subjects by Electrical Impedance Tomography
Guardando al domani: pensieri in dialogo
Il breve contributo si interroga sulle possibili connessioni tra mondo del volontariato, la scuola e l'universit\ue0, al fine di consolidare delle collaborazioni che abbiano una finalit\ue0 educativa e attente alla definizione di strumenti valutativi efficaci
Extracorporeal carbon dioxide removal through ventilation of acidified dialysate: An experimental study
Background: Extracorporeal (EC) carbon dioxide (CO2) removal (ECCO2R) may be a powerful alternative to ventilation, possibly avoiding the need for mechanical ventilation and endotracheal intubation. We previously reported how an infusion of lactic acid before a membrane lung (ML) effectively enhances ECCO2R. We evaluated an innovative ECCO2R technique based on ventilation of acidified dialysate. Methods: Four swine were sedated, mechanically ventilated, and connected to a venovenous dialysis circuit (blood flow, 250 ml/min). The dialysate was recirculated in a closed loop circuit including a ML (gas flow, 10 liters/min) and then returned to the dialyzer. In each animal, 4 different dialysis flows (DF) of 200, 400, 600, and 800 ml/min were evaluated with and without lactic acid infusion (2.5 mEq/min); the sequence was completed 3 times. At the end of each step, we measured the volume of CO2R by the ML (Vco2ML) and collected blood and dialysate samples for gas analyses. Results: Acid infusion substantially increased Vco2ML, from 33 \uc2\ub1 6 ml/min to 86 \uc2\ub1 7 ml/min. Different DFs had little effect on Vco2ML, which was only slightly reduced at DF 200 ml/min. The partial pressure of CO2of blood passing through the dialysis filter changed from 60.9 \uc2\ub1 3.6 to 37.1 \uc2\ub1 4.8 mm Hg without acidification and to 32.5 \uc2\ub1 5.3 mm Hg with acidification, corresponding to a pH increase of 0.18 \uc2\ub1 0.03 and 0.03 \uc2\ub1 0.04 units, respectively. Conclusions: Ventilation of acidified dialysate efficiently increased ECCO2R of an amount corresponding to 35% to 45% of the total CO2production of an adult man from a blood flow as low as 250 ml/min. \uc2\ua9 2014 International Society for Heart and Lung Transplantation. All rights reserved
Analysis of the Pseudouridimycin Biosynthetic Pathway Provides Insights into the Formation of C-nucleoside Antibiotics
Pseudouridimycin (PUM) is a selective nucleoside-analog inhibitor of bacterial RNA polymerase with activity against Gram-positive and Gram-negative bacteria. PUM, produced by Streptomyces sp. ID38640, consists of a formamidinylated, N-hydroxylated Gly-Gln dipeptide conjugated to 5âČ-aminopseudouridine. We report the characterization of the PUM gene cluster. Bioinformatic analysis and mutational knockouts of pum genes with analysis of accumulated intermediates, define the PUM biosynthetic pathway. The work provides the first biosynthetic pathway of a C-nucleoside antibiotic and reveals three unexpected features: production of free pseudouridine by the dedicated pseudouridine synthase, PumJ; nucleoside activation by specialized oxidoreductases and aminotransferases; and peptide-bond formation by amide ligases. A central role in the PUM biosynthetic pathway is played by the PumJ, which represents a divergent branch within the TruD family of pseudouridine synthases. PumJ-like sequences are associated with diverse gene clusters likely to govern the biosynthesis of different classes of C-nucleoside antibiotics. Sosio et al. describe the biosynthetic pathway for the C-nucleoside antibiotic pseudouridimycin. Biosynthesis proceeds through formation of pseudouridine by the pseudouridine synthase PumJ, with specialized oxidoreductase, aminotransferase, and amide ligases leading to the final compound. Microbial genomes harbor diverse gene clusters encoding PumJ-related sequences
Antibacterial Paramagnetic Quinones from <i>Actinoallomurus</i>
Four metabolites, designated paramagnetoquinone
A, B, C, and D (<b>1</b>â<b>4</b>), were isolated
from three strains belonging to the actinomycete genus <i>Actinoallomurus</i>. Compounds <b>1</b> and <b>2</b> showed potent antibacterial
activity with MIC values lower than 0.015 ÎŒg/mL against Gram-positive
pathogens, including antibiotic-resistant strains. Since compounds <b>1</b> and <b>2</b> were NMR-silent due to the presence of
an oxygen radical, structure elucidation was achieved through a combination
of derivatizations, oxidations, and analysis of <sup>13</sup>C-labeled
compounds. The paramagnetoquinones share the same carbon scaffold
as tetracenomycin but carry two quinones and a five-membered lactone
fused to the aromatic system. Compounds <b>2</b> and <b>1</b> are identical except for an unprecedented replacement of a methoxy
in <b>2</b> by a methylamino group in <b>1</b>. Related
compounds devoid of methyl group(s) and of antibacterial activity
were isolated from a different <i>Actinoallomurus</i> strain.
The likely <i>pmq</i> biosynthetic gene cluster was identified
from strain ID145113. While the cluster encodes many of the expected
enzymes involved in the formation of aromatic polyketides, it also
encodes a dedicated ketoacid dehydrogenase complex and an unusual
acyl carrier protein transacylase, suggesting that an unusual starter
unit might prime the polyketide synthase
Effective approaches to discover new microbial metabolites in a large strain library
Natural products have provided many molecules to treat and prevent illnesses in humans, animals and plants. While only a small fraction of the existing microbial diversity has been explored for bioactive metabolites, tens of thousands of molecules have been reported in the literature over the past 80 years. Thus, the main challenge in microbial metabolite screening is to avoid the re-discovery of known metabolites in a cost-effective manner. In this perspective, we report and discuss different approaches used in our laboratory over the past few years, ranging from bioactivity-based screening to looking for metabolic rarity in different datasets to deeply investigating a single Streptomyces strain. Our results show that it is possible to find novel chemistry through a limited screening effort, provided that appropriate selection criteria are in place
- âŠ